AMN
Basic information
Region (hg38): 14:102922663-102933596
Links
Phenotypes
GenCC
Source:
- Imerslund-Grasbeck syndrome (Supportive), mode of inheritance: AR
- Imerslund-Grasbeck syndrome type 1 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Imerslund-Grasbeck syndrome 2 | AR | Gastrointestinal | Early diagnosis is beneficial, as early detection may allow life-long medical treatment with parenteral hydroxocobalamin, which can ameliorate morbidity and mortality | Gastrointestinal; Hematologic; Renal | 12590260; 17114957; 17285242; 18181028; 22078000; 22854512; 22631584 |
ClinVar
This is a list of variants' phenotypes submitted to
- Imerslund-Grasbeck syndrome (23 variants)
- Imerslund-Grasbeck syndrome type 2 (5 variants)
- Imerslund-Grasbeck syndrome type 1 (2 variants)
- not provided (1 variants)
- Cobalamin deficiency;Megaloblastic anemia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AMN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 196 | 197 | ||||
missense | 74 | 81 | ||||
nonsense | 10 | |||||
start loss | 0 | |||||
frameshift | 16 | 21 | ||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 14 | 15 | ||||
splice region | 8 | 40 | 48 | |||
non coding | 137 | 18 | 160 | |||
Total | 27 | 19 | 82 | 340 | 20 |
Highest pathogenic variant AF is 0.000125
Variants in AMN
This is a list of pathogenic ClinVar variants found in the AMN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-102922666-G-C | Benign (Jul 15, 2018) | |||
14-102922695-G-C | Inborn genetic diseases | Uncertain significance (Nov 18, 2022) | ||
14-102922699-TG-T | Imerslund-Grasbeck syndrome type 2 • Imerslund-Grasbeck syndrome | Pathogenic (Jan 18, 2024) | ||
14-102922709-C-A | Imerslund-Grasbeck syndrome | Likely benign (Jan 15, 2024) | ||
14-102922709-C-T | Imerslund-Grasbeck syndrome | Likely benign (Oct 18, 2023) | ||
14-102922712-G-T | Imerslund-Grasbeck syndrome | Likely benign (Jul 13, 2023) | ||
14-102922722-C-T | Imerslund-Grasbeck syndrome | Pathogenic (Jan 24, 2024) | ||
14-102922722-CA-C | Imerslund-Grasbeck syndrome type 2 | Pathogenic (May 19, 2020) | ||
14-102922731-G-T | Imerslund-Grasbeck syndrome | Uncertain significance (Apr 22, 2022) | ||
14-102922732-G-T | Imerslund-Grasbeck syndrome | Likely pathogenic (-) | ||
14-102922738-C-T | Imerslund-Grasbeck syndrome | Likely benign (Jul 19, 2023) | ||
14-102922739-G-A | Imerslund-Grasbeck syndrome | Likely benign (Aug 12, 2021) | ||
14-102922740-G-A | Imerslund-Grasbeck syndrome | Likely benign (Nov 20, 2023) | ||
14-102922741-G-A | Imerslund-Grasbeck syndrome | Likely benign (Nov 23, 2022) | ||
14-102922742-A-G | Imerslund-Grasbeck syndrome | Likely benign (May 13, 2023) | ||
14-102922746-C-T | Imerslund-Grasbeck syndrome | Likely benign (Sep 26, 2023) | ||
14-102922746-CACCGGTGCGGGCCCGGACGGT-C | Imerslund-Grasbeck syndrome | Likely benign (Sep 27, 2023) | ||
14-102922747-A-G | Imerslund-Grasbeck syndrome | Likely benign (Nov 21, 2023) | ||
14-102922748-C-G | Imerslund-Grasbeck syndrome | Likely benign (Jun 25, 2023) | ||
14-102922748-C-T | Imerslund-Grasbeck syndrome | Likely benign (Sep 24, 2023) | ||
14-102922749-C-T | Imerslund-Grasbeck syndrome | Likely benign (Aug 29, 2023) | ||
14-102922877-C-T | Benign (Jul 31, 2018) | |||
14-102923017-T-C | Likely benign (Sep 21, 2020) | |||
14-102923691-C-T | Imerslund-Grasbeck syndrome | Likely benign (Apr 20, 2023) | ||
14-102923696-T-C | Imerslund-Grasbeck syndrome | Likely benign (Nov 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AMN | protein_coding | protein_coding | ENST00000299155 | 12 | 10941 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000265 | 0.985 | 125471 | 0 | 37 | 125508 | 0.000147 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.606 | 230 | 257 | 0.894 | 0.0000126 | 2784 |
Missense in Polyphen | 65 | 66.067 | 0.98385 | 775 | ||
Synonymous | -0.756 | 134 | 123 | 1.09 | 0.00000652 | 1017 |
Loss of Function | 2.17 | 9 | 19.3 | 0.467 | 8.29e-7 | 215 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000931 | 0.0000905 |
Ashkenazi Jewish | 0.000100 | 0.0000995 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000199 | 0.000176 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.000362 | 0.000359 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Necessary for efficient absorption of vitamin B12 (PubMed:12590260, PubMed:14576052). Required for normal CUBN- mediated protein transport in the kidney. May direct the production of trunk mesoderm during development by modulating a bone morphogenetic protein (BMP) signaling pathway in the underlying visceral endoderm (By similarity). {ECO:0000250|UniProtKB:Q99JB7, ECO:0000269|PubMed:14576052, ECO:0000305|PubMed:12590260}.;
- Disease
- DISEASE: Recessive hereditary megaloblastic anemia 1 (RH-MGA1) [MIM:261100]: Due to selective malabsorption of vitamin B12. Defects in vitamin B12 absorption lead to impaired function of thymidine synthase. As a consequence DNA synthesis is interrupted. Rapidly dividing cells involved in erythropoiesis are particularly affected. {ECO:0000269|PubMed:12590260, ECO:0000269|PubMed:22631584}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- HDL clearance;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism;Plasma lipoprotein clearance;Transport of small molecules;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Plasma lipoprotein assembly, remodeling, and clearance
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.0807
- hipred
- N
- hipred_score
- 0.329
- ghis
- 0.467
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.208
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Amn
- Phenotype
- cellular phenotype; skeleton phenotype; embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;
Gene ontology
- Biological process
- receptor-mediated endocytosis;multicellular organism development;excretion;cobalamin metabolic process;cobalamin transport;high-density lipoprotein particle clearance;Golgi to plasma membrane protein transport
- Cellular component
- extracellular space;plasma membrane;clathrin-coated pit;endosome membrane;integral component of membrane;apical plasma membrane;endocytic vesicle;brush border membrane;protein-containing complex;extracellular exosome
- Molecular function
- signaling receptor binding